TOX4 and its binding partners recognize DNA adducts generated by platinum anticancer drugs

Arch Biochem Biophys. 2011 Mar 15;507(2):296-303. doi: 10.1016/ Epub 2010 Dec 22.


Platinating agents are commonly prescribed anticancer drugs damaging DNA. Induced lesions are recognized by a wide range of proteins. These are involved in cellular mechanisms such as DNA repair, mediation of cytotoxicity or chromatin remodeling. They therefore constitute crucial actors to understand pharmacology of these drugs. To expand our knowledge about this subproteome, we developed a ligand fishing trap coupled to high throughput proteomic tools. This trap is made of damaged plasmids attached to magnetic beads, and was exposed to cell nuclear extracts. Retained proteins were identified by nanoHPLC coupled to tandem mass spectrometry. This approach allowed us to establish a list of 38 proteins interacting with DNA adducts generated by cisplatin, oxaliplatin and satraplatin. Some of them were already known interactome members like high mobility group protein 1 (HMGB1) or the human upstream binding factor (hUBF), but we also succeeded in identifying unexpected proteins such as TOX HMG box family member 4 (TOX4), phosphatase 1 nuclear targeting subunit (PNUTS), and WD repeat-containing protein 82 (WDR82), members of a recently discovered complex. Interaction between TOX4 and platinated DNA was subsequently validated by surface plasmon resonance imaging (SPRi). These interactions highlight new cellular responses to DNA damage induced by chemotherapeutic agents.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemistry*
  • Cell Nucleus / metabolism
  • DNA Adducts / chemistry*
  • DNA Adducts / genetics
  • DNA Adducts / metabolism*
  • HeLa Cells
  • Humans
  • Ligands
  • Magnetics
  • Neoplasm Proteins / metabolism*
  • Organoplatinum Compounds / chemistry*
  • Plasmids / genetics
  • Protein Binding
  • Proteomics
  • Surface Plasmon Resonance


  • Antineoplastic Agents
  • DNA Adducts
  • Ligands
  • Neoplasm Proteins
  • Organoplatinum Compounds
  • TOX4 protein, human